No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
JMP Securities Initiates Inhibrx at Market Perform
Inhibrx Initiated at Market Perform by JMP Securities
Inhibrx Biosciences Analyst Ratings
JMP Securities Maintains Inhibrx Biosciences(INBX.US) With Hold Rating
Inhibrx Biosciences: Hold Rating Justified by Financial Stability and Clinical Pipeline Potential
Inhibrx Biosciences Files to Sell 2.45M Shares of Common Stock for Holders